These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 4537669)

  • 1. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 2. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 5. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid.
    Schlesinger K; Boggan W; Freedman DX
    Life Sci; 1968 Apr; 7(7):437-47. PubMed ID: 4385105
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 13. Central effects of 3,4-dihydroxyphenylalanine and 5-hydroxytryptophane on tetrabenazine pretreated rabbits with special reference to the possible role of catecholamine and serotonin in the brain.
    Takagi H; Satoh M; Yamatsu K; Kimura K; Nakama M
    Int J Neuropharmacol; 1968 May; 7(3):265-73. PubMed ID: 5305181
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 15. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 16. DL-5-hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
    Fuxe K; Butcher LL; Engel J
    J Pharm Pharmacol; 1971 Jun; 23(6):420-4. PubMed ID: 4397180
    [No Abstract]   [Full Text] [Related]  

  • 17. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of reserpine on the toxicity of a cytotoxic alkylating agent].
    Kimura H
    Nihon Yakurigaku Zasshi; 1966 May; 62(3):96-104. PubMed ID: 5297152
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of catecholamines on the central nervous system. (1). Role of dopamine in the brain in animal behavioral changes].
    Kameyama T; Kisara K
    Nihon Yakurigaku Zasshi; 1966 Sep; 62(5):317-26. PubMed ID: 5298294
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on shock-elicited aggression in mice of preferentially protecting brain monoamines against the depleting action of reserpine.
    Butcher LL; Dietrich AP
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):61-70. PubMed ID: 4350470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.